Coral Laboratories Ltd (CORL)

Currency in INR
575.80
-2.20(-0.38%)
Delayed Data·
CORL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CORL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
565.00576.90
52 wk Range
560.70999.00
Key Statistics
Bid/Ask
568.05 / 575.65
Prev. Close
578
Open
570.55
Day's Range
565-576.9
52 wk Range
560.7-999
Volume
366
Average Volume (3m)
1.29K
1-Year Change
-17.78%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CORL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Coral Laboratories Ltd Company Profile

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally. The company offers antibiotics/antibacterial products, including antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant products, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic products, antimalarial drugs, antipsychotic drugs, thyroid, and kits, oral antiseptic preparations, mouthwashes; nutritional, protein, and iron supplements, calcium preparations, appetizers; and other products. It also offers cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. Further, the company provides its products in various dosage forms, including tablets, capsules, liquid orals, liquids and powders, dry syrups, eye/ear drops, ointment and creams, gels and lotions, B-lactam, low RH facilities, granules powder, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Employees
142
Market
India

Compare CORL to Peers and Sector

Metrics to compare
CORL
Peers
Sector
Relationship
P/E Ratio
8.5x35.9x−0.5x
PEG Ratio
0.160.240.00
Price/Book
1.0x3.5x2.6x
Price / LTM Sales
1.8x3.9x3.3x
Upside (Analyst Target)
-13.3%43.5%
Fair Value Upside
Unlock9.6%6.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 67.61%
Dividend Yield
0.35%
Industry Median 0.73%
Annualised payout
2.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
7.91 / --
Revenue / Forecast
306.16M / --
EPS Revisions
Last 90 days

CORL Income Statement

People Also Watch

385.05
BAJE
-1.19%
1,285.90
MGAS
-0.53%
258.00
KARU
-1.45%
240.50
REDI
+0.54%
107.35
CNBK
-1.31%

FAQ

What Stock Exchange Does Coral Laboratories Trade On?

Coral Laboratories is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Coral Laboratories?

The stock symbol for Coral Laboratories is "CORL."

What Is the Coral Laboratories Market Cap?

As of today, Coral Laboratories market cap is 2.02B.

What Is Coral Laboratories's Earnings Per Share (TTM)?

The Coral Laboratories EPS (TTM) is 67.61.

From a Technical Analysis Perspective, Is CORL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Coral Laboratories Stock Split?

Coral Laboratories has split 0 times.

How Many Employees Does Coral Laboratories Have?

Coral Laboratories has 142 employees.

What is the current trading status of Coral Laboratories (CORL)?

As of 07 Aug 2025, Coral Laboratories (CORL) is trading at a price of 575.80, with a previous close of 578.00. The stock has fluctuated within a day range of 565.00 to 576.90, while its 52-week range spans from 560.70 to 999.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.